Marc Oczachowski - EDAP TMS CEO
| EDAP Stock | USD 6.84 0.25 3.53% |
CEO
Mr. Marc Oczachowski was Chief Executive Officer and Director of Edap Tms SA since 2012. Prior to this, he served as Chief Executive Officer, President HIFU Division and UDS Division of the Company from March 31, 2007 to 2012. In November 2004, he became Chief Operating Officer of the Company. He joined the Company in May 1997 as Area Sales Manager, based in Lyon, France. Previously, he worked for Sodem Systems, which manufactures orthopedic power tools, as Area Sales Manager. He is a graduate of Institut Commercial de Lyon, France. since 2012.
| Age | 54 |
| Tenure | 12 years |
| Address | Parc dActivites la Poudrette-Lamartine, Lyon, France, 69120 |
| Phone | 33 4 72 153 150 |
| Web | https://www.edap-tms.com |
EDAP TMS Management Efficiency
The company has return on total asset (ROA) of (0.1065) % which means that it has lost $0.1065 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3295) %, meaning that it created substantial loss on money invested by shareholders. EDAP TMS's management efficiency ratios could be used to measure how well EDAP TMS manages its routine affairs as well as how well it operates its assets and liabilities. As of 04/25/2024, Return On Tangible Assets is likely to grow to -0.22. In addition to that, Return On Capital Employed is likely to grow to -0.29. At this time, EDAP TMS's Non Current Liabilities Total is relatively stable compared to the past year. As of 04/25/2024, Change To Liabilities is likely to grow to about 1.4 M, while Total Current Liabilities is likely to drop slightly above 16.2 M.Similar Executives
| Showing other executives | CEO Age | ||
| Donald Casey | Cardinal Health | 57 | |
| James Breslawski | Henry Schein | 70 | |
| John Adent | Patterson Companies | 47 | |
| Michael Kaufmann | Cardinal Health | 58 | |
| Jon Giacomin | Cardinal Health | 52 | |
| Donald Zurbay | Patterson Companies | 56 | |
| Lonnie Shoff | Henry Schein | 56 | |
| Edward Pesicka | Owens Minor | 56 | |
| Brian Tyler | McKesson | 57 | |
| Jonathan Koch | Henry Schein | 43 | |
| Stephen Mason | Cardinal Health | 52 | |
| Karen Prange | Henry Schein | 52 | |
| Victor Crawford | Cardinal Health | 59 | |
| Cody Phipps | Owens Minor | 55 | |
| Mark Walchirk | Patterson Companies | 50 | |
Management Performance
| Return On Equity | -0.33 | ||||
| Return On Asset | -0.11 |
EDAP TMS SA Leadership Team
Elected by the shareholders, the EDAP TMS's board of directors comprises two types of representatives: EDAP TMS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EDAP. The board's role is to monitor EDAP TMS's management team and ensure that shareholders' interests are well served. EDAP TMS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EDAP TMS's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Argil Wheelock, Independent Director | ||
| Ken Mobeck, Chief Officer | ||
| Pierre Beysson, Independent Director | ||
| Frank Hyfte, VP Marketing | ||
| Marc Oczachowski, CEO and President of Edap Tms France Sas and President of Edap Technomed Inc | ||
| Ryan Rhodes, CEO Director | ||
| Carre Emmanuel, Chief Officer | ||
| JeanFrancois Bachelard, President Ltd | ||
| Frederic Pech, President France | ||
| Blandine Confort, Investor Relations Officer | ||
| Philippe Chauveau, Independent Chairman of the Board | ||
| Francois Dietsch, Global Officer | ||
| Robrecht Michiels, Independent Director |
EDAP Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EDAP TMS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.33 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.35) % | ||||
| Operating Margin | (0) % | ||||
| Current Valuation | 228.08 M | ||||
| Shares Outstanding | 37.1 M | ||||
| Shares Owned By Institutions | 43.16 % | ||||
| Number Of Shares Shorted | 104.09 K | ||||
| Price To Earning | 107.40 X | ||||
| Price To Book | 4.64 X |
Pair Trading with EDAP TMS
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EDAP TMS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EDAP TMS will appreciate offsetting losses from the drop in the long position's value.Moving together with EDAP Stock
| 0.67 | NXL | Nexalin Technology | PairCorr |
Moving against EDAP Stock
| 0.85 | UNH | UnitedHealth Group Financial Report 12th of July 2024 | PairCorr |
| 0.8 | BBLG | Bone Biologics Corp Financial Report 20th of May 2024 | PairCorr |
| 0.66 | HSTM | HealthStream | PairCorr |
| 0.64 | HCAT | Health Catalyst Financial Report 14th of May 2024 | PairCorr |
| 0.64 | NAOV | NanoVibronix | PairCorr |
The ability to find closely correlated positions to EDAP TMS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EDAP TMS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EDAP TMS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EDAP TMS SA to buy it.
The correlation of EDAP TMS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EDAP TMS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EDAP TMS SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EDAP TMS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EDAP TMS SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the EDAP TMS SA information on this page should be used as a complementary analysis to other EDAP TMS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for EDAP Stock analysis
When running EDAP TMS's price analysis, check to measure EDAP TMS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EDAP TMS is operating at the current time. Most of EDAP TMS's value examination focuses on studying past and present price action to predict the probability of EDAP TMS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EDAP TMS's price. Additionally, you may evaluate how the addition of EDAP TMS to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is EDAP TMS's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EDAP TMS. If investors know EDAP will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EDAP TMS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.62) | Earnings Share (0.61) | Revenue Per Share 1.633 | Quarterly Revenue Growth 0.248 | Return On Assets (0.11) |
The market value of EDAP TMS SA is measured differently than its book value, which is the value of EDAP that is recorded on the company's balance sheet. Investors also form their own opinion of EDAP TMS's value that differs from its market value or its book value, called intrinsic value, which is EDAP TMS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EDAP TMS's market value can be influenced by many factors that don't directly affect EDAP TMS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EDAP TMS's value and its price as these two are different measures arrived at by different means. Investors typically determine if EDAP TMS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EDAP TMS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.